These observations suggest that during relapses GBMs may accumulate additional molecular alterations and evolve along two distinct pathways acquiring type 1 GBM profile (harboring p53 mutation) or type 2 GBM profile (harboring EGFR amplification), depending on the profile of the original tumor [7]. Here, EGFR is linked to glioblastoma.